The Patent Finder

Melbourne Health

7 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

4
Ending by 2030
Aug 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 15, 2027
    The maintenance fee for Barley with low levels of hordeins (US 9,133,427) comes due Mar 15, 2027. Unpaid by Sep 15, 2027, it lapses early.
  • 1 fee due Apr 3, 2027
    The maintenance fee for Methods and compositions for the treatment of hepatitis B infection (US 11,773,141) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
  • 1 fee due Jun 10, 2027
    The maintenance fee for Barley with Low Levels of Hordeins (US 10,501,712) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

PatentTitleStatus Expires Confidence
US 9,133,427Barley with low levels of hordeins
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,501,712Barley with Low Levels of Hordeins
In force
 · Medium confidence
In forceMedium confidence
US 11,326,134Barley with Low Levels of Hordeins
In force
 · Low confidence
In forceLow confidence
US 8,642,846Barley with Low Levels of Hordeins
In force
 · High confidence
In forceHigh confidence
US 12,202,862Methods and compositions for the treatment of hepatitis B infection
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,773,141Methods and compositions for the treatment of hepatitis B infection
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,364,256Viral inhibition
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 7: 17 lapsed for an unpaid fee · 7 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 8 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited